Analgesic, Non-ulcerogenic and Antioxidant Activities of the Aqueous Stem Bark Extract of Morinda lucida (Rubiaceae) in Mice
Mezui Christophe, Amang André Perfusion, Bougnom Blaise Pascal, Malepa Meda Ginette, Tchinda Fokoua Serges, Tchapmeni Fando Liliane, Tan Paul Vernyuy
Journal of Applied Life Sciences International · pp. 1–10 · Published 17 May 2017
10.9734/JALSI/2017/33003Abstract
Aims: The objective of this study was to evaluate the analgesic; non ulcerogenic and antioxidant effects of the aqueous stem bark extract of Morinda lucida in mice. Place and Duration of Study: Department of Biological Sciences, Higher Teachers’ Training College; Department of Animal Biology and Physiology and Department of Microbiology, Faculty of Science, University of Yaoundé I. Between August 2015 and November 2016. Materials and Methods: The phytochemical sifting was realized in other to find the chemical composition of the aqueous stem bark extract of Morinda lucida (ASBEML). The antioxydant activity was evaluated by the measurement the capacity of ASBEML to trap radical DPPH, to reduce Fe3 +, and measures it total polyphenols. The effects of ASBEML were tested on models of acute pain induced by acetic acid and formalin in mouse fasted since 12 hours. The ulcerogenic effect of this plant was evaluated by administration of different doses of the aqueous extract to mouse fasted since 48 hours. Results: The phytochemical tests revealed the presence of phenolics, flavonoïds, catechic tannins, alkaloids, saponins and triterpenes. The DPPH, FRAP and Folin-Ciocalteu tests showed that the aqueous stem bark extract of Morinda lucida has a significant antioxydant activity. The oral administration of ASBEML significantly and dose dependently reduced the number of abdominal constrictions induced by injection of acetic acid. A maximum inhibition of 80.20% was obtained at the dose of 400 mg/kg. Also, this extract (400 mg/kg) significantly and dose dependently inhibited both phases of pain induced by formalin injection; the first phase was reduced up to 53.7% while the second phase was reduced up to 75.88%. The oral administration of ASBEML doesn’t caused gastric ulcer. On the contrary, it significantly and dose dependently stimulated the mucus secretion. Conclusion: In sum, the ASBEML possesses antioxidant, analgesic (centrally and peripherally) and non-ulcerogenic properties.
Cited by 0
No indexed citations yet.
Related research
- Does Pain Adversely Affect the Quality of Life in Hospitalized Cancer Patients? — shares topic coverage
- Effects of Application of Night Splint in the Management of Plantar Fasciitis — shares topic coverage
- Illness Behavior: Pain Clinic Patients vs. Psychiatry Clinic Patients — shares topic coverage
- Using Generalized Estimating Equations to Compare the Effect of Two Methods in the Treatment of Knee Osteoarthritis — shares topic coverage
- Pharmacological Properties of Papaver rhoaes L. — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.